PropertyValue
?:abstract
  • DISCLOSURES: No funding supported the writing of this letter. The author is an unpaid member of the ICER Methods Advisory Committee and has participated in discussions at ICER meetings and meetings of the New England Comparative Effectiveness Advisory Council (CEPAC).
is ?:annotates of
?:creator
?:journal
  • J_Manag_Care_Spec_Pharm
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • ICER\'s Version of HTA Is Positioned to Guide U.S. Health Care Reform
?:type
?:who_covidence_id
  • #926031
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/bqtrjtph>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/bqtrjtph>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all